Abstract:Due to the tremendous heterogeneity of disease manifestations, many complex diseases that were once thought to be single diseases are now considered to have disease subtypes. Disease subtyping analysis, that is the identification of subgroups of patients with similar characteristics, is the first step to accomplish precision medicine. With the advancement of high-throughput technologies, omics data offers unprecedented opportunity to reveal disease subtypes. As a result, unsupervised clustering analysis has been widely used for this purpose. Though promising, the subtypes obtained from traditional quantitative approaches may not always be clinically meaningful (i.e. correlate with clinical outcomes). On the other hand, the collection of rich clinical data in modern epidemiology studies has the great potential to facilitate the disease subtyping process via omics data and to discovery clinically meaningful disease subtypes. Thus, we developed an outcome-guided Bayesian clustering (GuidedBayesianClustering) method to fully integrate the clinical data and the high-dimensional omics data. A Gaussian mixed model framework was applied to perform sample clustering; a spike-and-slab prior was utilized to perform gene selection; a mixture model prior was employed to incorporate the guidance from a clinical outcome variable; and a decision framework was adopted to infer the false discovery rate of the selected genes. We deployed conjugate priors to facilitate efficient Gibbs sampling. Our proposed full Bayesian method is capable of simultaneously (i) obtaining sample clustering (disease subtype discovery); (ii) performing feature selection (select genes related to the disease subtype); and (iii) utilizing clinical outcome variable to guide the disease subtype discovery. The superior performance of the GuidedBayesianClustering was demonstrated through simulations and applications of breast cancer expression data and Alzheimer's disease. An R package has been made publicly available on GitHub to improve the applicability of our method.

A Bayesian hierarchical hidden Markov model for clustering and gene selection: Application to kidney cancer gene expression data

Outcome-guided Bayesian clustering for disease subtype discovery using high-dimensional transcriptomic data

Bayesian hidden Markov tree models for clustering genes with shared evolutionary history

Enhanced Bayesian Gaussian hidden Markov mixture clustering for improved knowledge discovery

Bayesian Bi-clustering Methods with Applications in Computational Biology

Sparse Bayesian Hierarchical Modeling of High-dimensional Clustering Problems

Bayesian Nonparametric Variable Selection as an Exploratory Tool for Finding Genes that Matter

Incorporating biological information into linear models: A Bayesian approach to the selection of pathways and genes

Robust model-based clustering with gene ranking

Integrative Model-based clustering of microarray methylation and expression data

A bayesian multivariate mixture model for high throughput spatial transcriptomics

BELMM: Bayesian model selection and random walk smoothing in time-series clustering

Analysis of a Gibbs sampler method for model based clustering of gene expression data

Non-parametric Bayesian modelling of digital gene expression data

Bayesian Models for Heterogeneous Personalized Health Data

Bayesian outcome-guided multi-view mixture models with applications in molecular precision medicine

Bayesian clustering of replicated time-course gene expression data with weak signals

Mining gene expression data using a novel approach based on hidden Markov models.

EBSeq-HMM: a Bayesian Approach for Identifying Gene-Expression Changes in Ordered RNA-seq Experiments

Gene Hunting with Knockoffs for Hidden Markov Models

A Clustering Approach to Integrative Analysis of Multiomic Cancer Data